• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 厚生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

厚生

(2107)
可現股當沖
  • 股價
    25.90
  • 漲跌
    ▲0.30
  • 漲幅
    +1.17%
  • 成交量
    207張
  • 產業
    上市 橡膠類股

  • 201人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
厚生 (2107)籌碼相關－元富-緯城 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

元富-緯城 券商分點個股進出

元富-緯城 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.000.525.6525.90-0.5232-0.22%
2025/01/1700.000.425.5025.70-0.4229-0.17%
2025/01/13225.2000.0025.2022290.87%
2025/01/0900.00125.7525.60-1222-0.45%
2025/01/08325.5000.0025.6032211.36%
2025/01/03325.5300.0025.5532201.36%
2024/12/31225.8000.0025.8022200.91%
2024/12/16525.8500.0025.8552312.16%
2024/12/1000.00226.5026.45-2221-0.90%
2024/12/09226.551426.4826.40-12221-5.42%
2024/12/0600.00226.2026.15-2219-0.91%
2024/11/25125.4000.0025.6012400.41%
2024/11/22325.4200.0025.4032411.24%
2024/11/21325.3700.0025.3532481.21%
2024/11/20425.3900.0025.3542501.60%
2024/11/1500.00125.5525.55-1251-0.40%
2024/11/1400.00125.7525.50-1256-0.39%
2024/11/1100.00225.9525.90-2256-0.78%
2024/11/087525.9100.0025.757525828.97%
2024/10/0900.00525.8825.80-5598-0.83%
2024/10/08325.55125.7025.6025970.33%
2024/10/07225.70225.7025.7006000.00%
2024/10/04325.7500.0025.6536010.50%
2024/10/011525.7800.0025.75156042.48%
2024/09/24225.4000.0025.5026380.31%
2024/09/09225.5000.0025.7526620.30%
2024/09/04825.9300.0025.7586691.19%
2024/08/30226.6000.0026.7026660.30%
2024/08/29226.6000.0026.7026670.30%
2024/08/27227.0000.0027.0526820.29%
2024/08/2100.00626.7027.00-6682-0.88%
2024/08/1600.001127.0827.05-11700-1.57%
2024/08/1400.00226.5026.55-2701-0.29%
2024/08/0900.00426.2026.00-4698-0.57%
2024/08/08225.4500.0025.6527000.29%
2024/08/0700.00426.0526.00-4703-0.57%
2024/08/06424.60225.3525.3027080.28%
2024/08/051825.9100.0025.25187012.57%
2024/08/02827.3900.0027.4086831.17%
2024/08/0100.0010.928.1228.25-10.9672-1.62%
2024/07/3100.00627.6227.35-6645-0.93%
2024/07/30426.8500.0027.1546370.63%
2024/07/2900.00427.6827.60-4654-0.61%
2024/07/26627.2300.0027.1566510.92%
2024/07/231427.313927.9328.10-25671-3.72%
2024/07/22226.10126.5026.2516030.17%
2024/07/19426.3300.0026.4046050.66%
2024/07/1700.00526.9526.95-5612-0.82%
2024/07/1600.00227.0026.95-2646-0.31%
2024/07/1500.00426.9026.70-4653-0.61%
2024/07/1200.001226.4026.75-12654-1.83%
2024/07/1100.00226.2026.10-2645-0.31%
2024/07/0800.00625.5025.50-6659-0.91%
2024/07/05225.4000.0025.5026630.30%
2024/07/031225.4500.0025.40126761.77%
2024/06/2400.00227.2027.00-2660-0.30%
2024/06/2100.00227.1027.15-2660-0.30%
2024/06/2000.00427.0027.10-4660-0.61%
2024/06/1100.00226.9026.75-2654-0.31%
2024/06/0700.00226.7526.65-2665-0.30%
2024/06/0500.00126.5026.45-1657-0.15%
2024/06/0400.00426.6026.60-4657-0.61%
2024/05/24226.0000.0026.3026310.32%
2024/05/231026.2500.0026.25106341.57%
2024/05/21227.0000.0026.8526150.33%
2024/05/2000.00227.0526.95-2608-0.33%
2024/05/1700.00126.7026.80-1603-0.17%
2024/05/1000.00227.2026.95-2581-0.34%
2024/05/091226.6200.0026.35125682.11%
2024/05/08426.85627.3826.80-2559-0.36%
2024/05/074.126.560.126.5526.7045440.73%
2024/05/0200.00927.3327.40-9497-1.81%
2024/04/30426.4000.0026.7044640.86%
2024/04/29627.063226.8627.00-26449-5.78%
2024/04/2400.00226.0025.90-2394-0.51%
2024/04/23225.5000.0025.7523920.51%
2024/04/2230.126.09626.2525.6024.13846.26%
2024/04/190.125.504725.5025.55-46.9347-13.50%
2024/04/1800.00225.5025.55-2329-0.61%
2024/04/1700.000.125.0025.25-0.1322-0.02%
2024/04/16824.8900.0024.9583172.52%
2024/04/1500.001725.6825.45-17307-5.54%
2024/04/1200.00025.0025.4502990.00%
2024/04/1000.000.125.2025.45-0.1288-0.02%
2024/04/0900.00425.2825.15-4281-1.42%
2024/04/0800.00225.0025.00-2276-0.72%
2024/04/02224.50224.7524.7503110.00%
2024/03/211024.1700.0024.05102813.56%
2024/03/201024.2000.0024.05102793.58%
2024/03/131024.35424.3324.2562712.21%
2024/03/1200.00224.3023.95-2256-0.78%
2024/03/01123.7000.0023.7012540.39%
2024/02/261023.7000.0023.60102533.95%
2024/02/233023.8700.0023.753024612.19%
2024/02/1900.00223.8523.80-2247-0.81%
昱厚股東會／鼻噴新藥 AD17002積極拓展國際合作UDN聯合新聞網－2024/06/12
昱厚生技（6709）12日召開股東常會，董事長徐悠深表示，今年主軸加速推進嗜酸性白血球嚴重氣喘鼻噴新藥AD17002的臨......詳全文
向榮生技海外布局傳捷報 通過日本厚生省細胞培養加工設施查核Anue鉅亨－2024/05/15
...詳全文
昱厚生技盼加速鼻噴劑型應用 推進三產品臨床試驗Anue鉅亨－2023/06/30
...詳全文
厚生 相關文章
厚生 相關影音